top of page
About

ABOUT

NeoVac is a clinical stage company with a unique IP for Lipid Nanoparticles developed by Prof. Dan Peer.

 

Prof. Peer’s work was among the first to demonstrate systematic delivery of RNA molecules using targeted nanocarriers to the immune system. His lab was the first to show systemic cell specific delivery of mRNA and invented the first bacterial mRNA vaccine. In addition, he pioneered the use of mRNA and sgRNA for therapeutic genome editing in cancer. 

Co-founder Prof. Adrian Hill leads the Jenner Institute at Oxford University and oversees NeoVac’s clinical trial activities. Prof. Hill is a world-renowned vaccinologist, co-inventor of the Astra Zeneca Vaccine, an expert in malaria vaccines and leader of over 80 high-profile vaccine clinical trials.

OUR MISSION

NeoVac is creating revolutionary, unique and proprietary next-generation lipid nanoparticles to enable better RNA vaccines and treatments for various diseases.

Allowing more people around the world access to better vaccines and treatments - more transportable, with broader capabilities and fewer side effects. 

The Team

THE TEAM

HH_BW-web-2.png
TS_BW_WEB.png
SNZ_BW-web-2.png
MT_BW-WEB.png
SR_BW-web.png
AA_BW-web-2.png
IS_BW-web.png
srilanka-BW-web.png
MZ_BW-web.png
PG-BW-web.png
ED-BW-web.png
Contacts
bottom of page